Elevation of Neutrophil-to-Lymphocyte Ratio before First-Line Chemotherapy Predicts a Poor Prognosis for Second-Line Chemotherapy in Gastric Cancer.

CONCLUSIONS: Patients with advanced gastric cancer with performance status 2, hemoglobin < 10 g/dL, and NLR before first-line chemotherapy ≥3 are not likely to benefit from second-line chemotherapy.
PMID: 30368510 [PubMed - as supplied by publisher]

Source: Oncology - October 26, 2018 Category: Cancer & Oncology Authors: Inoue D, Sekiguchi S, Yamagata W, Maeda G, Yamada D, Fujiwara S, Itou S, Kurihara M, Hijioka Y, Shimoji K, Fujiki J, Nakazono A, Horike H, Yoshioka A, Ogura Y, Hatao F, Imamura K, Namiki S Tags: Oncology Source Type: research